{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:45:41Z","timestamp":1790063141792,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.nucmedbio.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T06:29:25Z","timestamp":1375252165000},"page":"831-840","source":"Crossref","is-referenced-by-count":20,"title":["Characterization of biological features of a rat F98 GBM model: A PET-MRI study with [18F]FAZA and [18F]FDG"],"prefix":"10.1016","volume":"40","author":[{"given":"Sara","family":"Belloli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brioschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letterio Salvatore","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ronchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Calderoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Raccagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Monterisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Zara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruccio","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Moresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0005","author":"Central Brain Tumor Registry of the United States (CBTRUS) statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004\u20132008 (revised March 23, 2012"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0010","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1101\/gad.891601","article-title":"Malignant glioma: genetics and biology of a grave matter","volume":"15","author":"Maher","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0015","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","article-title":"Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials","volume":"359","author":"Stewart","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0020","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","article-title":"Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival","volume":"14","author":"Spence","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0025","first-page":"106","article-title":"Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside","volume":"46","author":"Piert","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00259-009-1154-5","article-title":"Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)","volume":"36","author":"Postema","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physiol.00045.2008","article-title":"Regulation of oxygen homeostasis by hypoxia-inducible factor 1","volume":"24","author":"Semenza","year":"2009","journal-title":"Physiology (Bethesda)"},{"issue":"Suppl 5","key":"10.1016\/j.nucmedbio.2013.05.004_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","article-title":"Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0050","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/cncr.23678","article-title":"Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme","volume":"113","author":"Flynn","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3171\/jns.1985.62.6.0816","article-title":"Prediction of survival in glioma patients by means of positron emission tomography","volume":"62","author":"Patronas","year":"1985","journal-title":"J Neurosurg"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<115::AID-CNCR17>3.0.CO;2-7","article-title":"18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma","volume":"79","author":"Barker","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0065","first-page":"1667","article-title":"Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalations","volume":"43","author":"Tralins","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0070","first-page":"282","article-title":"Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant glioma","volume":"16","author":"Soritau","year":"2011","journal-title":"J BUON"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0075","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/neuonc\/nor039","article-title":"Pathway inhibition: emerging molecular targets for treating glioblastoma","volume":"13","author":"Wick","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0080","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/foc.2005.19.4.2","article-title":"Genetic characterization of commonly used glioma cell lines in the rat animal model system","volume":"19","author":"Sibenaller","year":"2005","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1017\/S0317167100006715","article-title":"Standardization and detailed characterization of the syngeneic Fischer\/F98 glioma model","volume":"34","author":"Mathieu","year":"2007","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0090","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.apradiso.2004.12.004","article-title":"Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation","volume":"62","author":"Reischl","year":"2005","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0895-6111(02)00034-4","article-title":"Use of a fast EM algorithm for 3D image reconstruction with the YAP-PET tomograph","volume":"26","author":"Motta","year":"2002","journal-title":"Comput Med Imaging Graph"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0100","first-page":"1519","article-title":"Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study","volume":"45","author":"Boellaard","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/S0317167100004753","article-title":"MR-pathological comparison in F98-Fischer glioma model using a human gantry","volume":"33","author":"Blanchard","year":"2006","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0110","first-page":"2359","article-title":"Correlation of FDG-PET interpretation with survival in a cohort of glioma patients","volume":"24","author":"Pardo","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/neuonc\/nor054","article-title":"Molecular imaging of gliomas with PET: opportunities and limitations","volume":"13","author":"la Fougere","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nucmedbio.2007.11.004","article-title":"Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET","volume":"35","author":"Tsuchida","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nucmedbio.2005.01.005","article-title":"Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model","volume":"32","author":"Wang","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-009-9827-2","article-title":"Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target","volume":"92","author":"Jensen","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0145","first-page":"781","article-title":"Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model","volume":"38","author":"Valable","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3171\/2011.5.JNS101954","article-title":"Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor","volume":"115","author":"Sheehan","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0155","first-page":"410","article-title":"Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies","volume":"47","author":"Cher","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2967\/jnumed.108.055467","article-title":"Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas","volume":"50","author":"Swanson","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00259-010-1645-4","article-title":"Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma","volume":"38","author":"Kawai","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0170","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","article-title":"Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging","volume":"10","author":"Rajendran","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0175","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","article-title":"Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression","volume":"88","author":"Zagzag","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00000478-199807000-00004","article-title":"Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma","volume":"22","author":"Chan","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.surneu.2006.10.050","article-title":"Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival","volume":"68","author":"Strojnik","year":"2007","journal-title":"Surg Neurol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.2007.047605","article-title":"Nestin expression in different tumours and its relevance to malignant grade","volume":"61","author":"Yang","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0195","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3171\/JNS\/2008\/108\/4\/0782","article-title":"A distinct phenotypic change in gliomas at the time of magnetic resonance imaging detection","volume":"108","author":"Jang","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1016\/j.nucmedbio.2013.05.004_bb0200","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jcp.2004.018606","article-title":"Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas","volume":"58","author":"Haapasalo","year":"2005","journal-title":"J Clin Pathol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T01:50:39Z","timestamp":1563587439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805113001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0969805113001054"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.05.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}